INTRODUCTION
============

Asthma is a chronic and complex disorder of the respiratory system characterized by airway obstruction and inflammation,[@B1] and its prevalence is increasing in both developed and developing countries.[@B2],[@B3] This increased prevalence may reflect increased exposure to environmental risk factors. Although environmental factors are important determinants of asthma, numerous studies have revealed that asthma has a strong genetic component. Susceptibility genes have been identified by candidate gene association studies, genome-wide linkage studies, and genome-wide association studies.[@B4] Many genes have been shown to make small contributions to the overall phenotype.

Toll-like receptors are an essential family of innate immune pattern recognition receptors that play a pivotal role in host defense against microbes.[@B5] TLRs can modulate the immune system through cellular activation, modulation of cytokine secretion[@B6] and production of soluble factors to local dendritic networks.[@B7] Human epidemiological studies have supported the common clinical perception that TLRs are associated with asthma. These studies have varied in design, population composition, asthma definition and size. Macrophages, one of the main immune cell types involved in asthma, express various TLRs, including *TLR2*, *4*, *5*, *6*, *7*, *8*, and *9*.[@B8] Each TLR recognizes different classes of molecules expressed by pathogens and recognizes structurally conserved motifs.[@B9]

*TLR1* and *6* recognize multiple diacyl peptides, and *TLR1/2* dimers can recognize lipopeptides.[@B10] *TLR2*, which has been found to be expressed by various cell types,[@B11] is related to protection against allergies and allergic asthma by sensing pathogen-associated patterns in lipoproteins and lipopeptides. The *TLR2/6* dimer is involved in the recognition of diacylated lipopeptides.[@B12] Long-term stimulation of *TLR3* upregulates the production of inflammatory cytokines and cellular recruitment to the airways.[@B13] *TLR4* encodes a macrophage cell-surface receptor, which is principally activated by bacterial endotoxin, also known as lipopolysaccharide (LPS). Few studies of the role of *TLR5* in asthma have been reported. However, a significant decrease in the expression of *TLR5* was observed in asthma patients,[@B14] and TLR5 recognizes bacterial flagellin when complexed with *TLR4*.[@B15] Similar to *TLR5*, few data exist on the role of *TLR6* in allergic asthma.[@B12] *TLR6* is expressed on mast cells, which play important roles in allergy.[@B16] *TLR7* and *TLR8*, which are localized on the sex chromosome Xp22,[@B17] recognize single-stranded RNA, and induce interferons (IFNs) to protect the host from viral infection.[@B18] *TLR9* detects bacterial or viral DNA with unmethylated cytosine and guanine.[@B8] *TLR10* is the most recently identified gene in the TLR family whose product recognizes pathogen-associated molecular patterns (PAMPs).[@B19] TLRs are also involved in various signaling pathways of the immune system that protect from asthma or develop asthma phenotypes.[@B20],[@B21],[@B22],[@B23],[@B24],[@B25]

Most studies published since 2004 have comprised genetic association investigations in various clinical settings, and have found positive associations of SNPs in *TLR2*,[@B26],[@B27],[@B28] *TLR4*,[@B29] *TLR6*,[@B30] *TLR7/8*,[@B31] *TLR9*,[@B32] and *TLR10*[@B19] with asthma. Recent insights into the complex mechanisms of human innate immunity have suggested that genetic variability in genes may play a role in the development of asthma and related diseases.[@B34],[@B35],[@B36],[@B37],[@B38]

Due to the important contribution of TLR genes to asthma, an updated meta-analysis was conducted to estimate the effect of SNPs in TLR genes on asthma susceptibility.

MATERIALS AND METHODS
=====================

Identification of eligible studies
----------------------------------

The review process followed the Preferred Reporting Items for Systematic Reviews and Meta-Analyses guidelines.[@B39] We performed a literature search using the MEDLINE and EMBASE databases to identify articles that examined associations between TLR polymorphisms and asthma. Combinations of keywords, such as \'TLR\', \'polymorphism\', and \'asthma\' were entered as medical subject heading (MeSH) and text words. References in the identified studies were used to identify additional studies not indexed by MEDLINE or EMBASE databases. No language or date restrictions were applied.

Inclusion and exclusion criteria
--------------------------------

Studies identified from the searches were screened and excluded from further analysis if one of the following reasons was satisfied: a review article, lack of information, animal research, not case-control or nested case-control study design, or unreported genotype frequencies.

For inclusion, the studies must have met the following criteria: (1) they evaluated TLR gene polymorphisms and asthma; (2) were case-control studies; (3) supplied the number of individual genotypes in asthmatic cases and in controls, respectively; or (4) they had an asthma outcome definition that followed accepted diagnostic guidelines.

Data extraction
---------------

Information was extracted carefully from all of the eligible publications independently by 2 authors, based on the inclusion criteria above. The following information was extracted from each study: author, year of study publication, ethnicity of the study population, demographics (age), asthma status, and number of cases and controls for each TLR polymorphism.

Statistical analysis
--------------------

Data from the studies were combined to provide a summary odds ratio (OR). Summary ORs were represented as a point estimate with 95% confidence intervals (CIs) on a forest plot.[@B40] The heterogeneity of the data was evaluated using the Q statistic.[@B41] The stability of the summary risk estimate was evaluated using a sensitivity analysis in which each study was removed individually, and the OR was recalculated. Egger\'s regression test was used to identify publication bias.[@B42]

RESULTS
=======

Study inclusion and characteristics
-----------------------------------

The initial search using the headings \'TLR\', \'polymorphism\' \'asthma\', and their combinations resulted in approximately 6,395 journal articles. Based on the titles, 110 were potentially relevant. Nineteen studies investigating general atopic and allergic phenotypes were excluded. An additional 25 studies on TLR polymorphism involvement in signaling pathways were excluded. Review articles (n=28) were also excluded. Seventeen studies were excluded because they did not meet the inclusion criteria: eight did not report genotypic frequencies in cases and/or in controls[@B24],[@B25],[@B38],[@B43],[@B44],[@B45],[@B46],[@B47]; two were cross-sectional studies[@B48],[@B49]; four were family-based studies,[@B50],[@B51],[@B52],[@B53] and 3 were abstracts.[@B54],[@B55],[@B56] Twenty case-control studies were eligible for meta-analysis,[@B19],[@B26],[@B27],[@B28],[@B29],[@B30],[@B31],[@B32],[@B33],[@B57],[@B58],[@B59],[@B60],[@B61],[@B62],[@B63],[@B64],[@B65],[@B66],[@B67] one study was in Portuguese,[@B62] and another was in Chinese.[@B64] Among the eligible studies, 11 were excluded because the number of studies of the same polymorphism was less than 3.

The controls for the studies by Lachheb et al.[@B32] and Zhang et al.[@B29] deviated from Hardy-Weinberg equilibrium (HWE) in the controls (*P*\<0.01). The study by Caravalho et al.[@B61] was small, and the definition of asthma was restricted to severe asthma with fungal sensitization. In the study by Palikhe et al.,[@B65] the definition of asthma was limited to aspirin-tolerant asthma. In the study by Yang et al.,[@B58] three sets of patients (first-affected sibling, second-affected sibling and asthmatic parents) were compared with hyper-normal controls. A meta-analysis was conducted when at least 3 studies on the same polymorphism were available. [Fig. 1](#F1){ref-type="fig"} provides a summary of the search results. [Table 1](#T1){ref-type="table"} summarizes the characteristics of the case-control studies.

Data analysis
-------------

### Association of TLR4 Asp299Gly with asthma risk

Analyses in the random effects model showed that the *TLR4 Asp299Gly* polymorphism was marginally associated with asthma under the recessive (0.069) ([Fig. 2](#F2){ref-type="fig"}) and allele contrast (0.055) models. In the allele contrast model, sensitivity analysis by exclusion of any one particular study[@B60] in the influence analysis significantly changed the results. The recalculated OR was 0.803 (95% CI, 0.647-0.997; *P*=0.047), indicating that the major A allele might protect against asthma ([Table 2](#T2){ref-type="table"}).

The estimated OR1 (AA vs GG), OR2 (AG vs GG) and OR3 (AA vs AG) were 0.897, 0.831, and 0.972, respectively. These estimates were likely to suggest a codominant genetic model. The pooled OR1 was 0.897 (95% CI, 0.597-1.346; *P*=0.599). Heterogeneity was absent (0.00%). No evidence of publication bias was detected by Egger\'s test (*P*=0.12). Sensitivity analysis by the removal of one study did not significantly change the results ([Table 2](#T2){ref-type="table"}).

### Association of TLR4 Thr399Ile C\>T with asthma risk

Analyses in the random-effects model showed that the *TLR4 Thr399Ile* polymorphism was not associated with asthma under any of the genetic models.

The estimated OR1 (CC vs TT), OR2 (CT vs TT) and OR3 (CC vs TC) were 1.223, 1.306, and 0.398, respectively. These estimates did not fit any genetic model. Analysis in the allele contrast model showed no significant association of the *TLR4 Thr399Ile* C allele with asthma risk (OR=1.223 \[95% CI, 0.655-2.286; *P*=0.528\]) ([Fig. 3](#F3){ref-type="fig"}). Heterogeneity was absent in all of the models (0.00%). Sensitivity analysis by the removal of one study did not significantly change the results. Publication bias was detected by Egger\'s test in the dominant and CC vs TC codominant models (*P*=0.05 and *P*=0.03, respectively) ([Table 2](#T2){ref-type="table"}).

### Association of TLR2 Arg753Gln G/A with asthma risk

Analyses showed that the *TLR2 Arg753Gln* polymorphism was not associated with asthma under the recessive, homozygous ([Fig. 4](#F4){ref-type="fig"}) and allele contrast models. In the homozygous model, sensitivity analysis by the removal of one study[@B61] significantly changed the results. The recalculated OR was 4.460 (95% CI, 1.213-16.396), indicating that the homozygous genotypes might be a significant risk factor (*P*=0.024). In the GG vs GA model, when one study was removed,[@B61] the recalculated OR was 4.365 (95% CI, 1.227-15.536), suggesting that the homozygous genotype might be a significant risk factor (*P*=0.023). Sensitivity analysis by the removal of one study[@B60] in the allele contrast model significantly changed the results. The recalculated OR was 0.402 (95% CI, 0.199-0.811), indicating that the major G allele might protect significantly against asthma (*P*=0.011).

The estimated OR1 (GG vs AA), OR2 (GA vs AA) and OR3 (GG vs GA) were 0.102, 0.01, and 2.451, respectively. These estimates did not fit any genetic model. Only three studies were available; therefore, estimates were not sufficiently powerful. However, these estimates provided a first indication that genotypes with at least one copy of the major G allele might be protective. No evidence of publication bias was detected by Egger\'s test in all of the genetic models ([Table 2](#T2){ref-type="table"}).

### Association of TLR9 -1237 T/C with asthma risk

Analyses showed that the *TLR9 -1237 T/C* polymorphism was not associated with asthma under the recessive, homozygous and codominant models. In the allele contrast model, the major T allele was marginally associated with asthma with OR=0.689 (95% CI, 0.471-1.007; *P*=0.055), suggesting that the major T allele might be a significant protective factor ([Table 2](#T2){ref-type="table"} and [Fig. 5](#F5){ref-type="fig"}).

The estimated OR1 (TT vs CC), OR2 (TC vs CC) and OR3 (TT vs TC) were 0.408, 0.01, and 0.498, respectively. These estimates likely suggested a codominant genetic model. Only three studies on *TLR9 -1237 T/C* were available; therefore, estimates were not sufficiently powerful. However, these estimates indicated that the TT genotype tended to be a significant protective factor (*P*=0.065). No evidence of publication bias was detected by Egger\'s test in all of the genetic models ([Table 2](#T2){ref-type="table"}).

DISCUSSION
==========

During the last decade, the function of TLRs in asthma pathogenesis has been investigated largely by comparing the incidence of disease among persons with different polymorphisms. The magnitude of the association of polymorphisms with asthma varies depending on genetics, demographics, environmental factors, and study methodologies. Many association studies have reported that TLR polymorphisms predispose to asthma.[@B26],[@B47],[@B49],[@B52],[@B56],[@B59],[@B61],[@B68] However, some polymorphisms might not be associated with asthma susceptibility, but rather with asthma severity, such as *TLR4* polymorphisms.[@B48],[@B51],[@B58] Conflicting results were also reported, demonstrating a protective effect of some polymorphisms.[@B12],[@B45],[@B46] However, other studies reported no association between TLR polymorphisms and asthma risk.[@B44],[@B50],[@B53],[@B60],[@B61],[@B64],[@B69],[@B70] Given the conflicting results yielded by genetic association studies, a systematic review and meta-analysis is of great value. The current meta-analysis provides a comprehensive examination of the available evidence concerning the association of SNPs in *TLR* genes with asthma and refines their risk profiles. This analysis represents the first meta-analysis concerning the impact of some *TLR* polymorphisms on asthma and assesses their role as modifiers of asthma risk.

Estimates of combined effect sizes revealed that the major *TLR9 -1237 T* allele was significantly associated with a decreased asthma risk. Additionally, for *TLR2 Arg753Gln* *G*\>*A*, sensitivity analysis in the allele contrast model revealed that the major G allele was significantly associated with a decreased asthma risk. For *TLR4 Asp299Gly* *A*\>*G*, the AA homozygote genotype and A allele tended to be associated with a decreased asthma risk. These results implicate that the major allele in *TLR* polymorphisms might be generally associated with a protective effect. However, *TLR4 Thr399Ile* showed no significant association with asthma risk. In a previous meta-analysis, Chen[@B71] reported no direct association between *TLR4 Asp299Gly* and asthma. This result is consistent with our findings in the dominant, homozygous and codominant models. In a recent systematic review, Klassen et al.[@B72] reported that *TLR 2*, *TLR6*, *TLR9*, and *TLR10* appear to have some association with childhood asthma in Caucasians. However, no convincing evidence for a role of TLRs in relation to childhood asthma exists. Polymorphisms in *TLR3* seemed not to be associated with asthma.[@B57],[@B65] Results for *TLR6* are conflicting. One study with a small sample size showed that *TLR6 Ser249Pro* *C*\>*T* contributed to asthma susceptibility,[@B30] but a larger study on the same polymorphism reported no association in both children and adults.[@B59] However, other studies reported that polymorphisms in TLR6 were significantly associated with asthma phenotypes.[@B44],[@B45],[@B56],[@B73] Similarly, some polymorphisms in *TLR7/8* have been shown to be associated with asthma disease,[@B29],[@B33] whereas other polymorphisms showed no association.[@B29] For *TLR10*, some polymorphisms showed significant association with asthma[@B23],[@B33],[@B45]; however, other polymorphisms showed no significant association.[@B27],[@B45] Genetic association studies on *TLR1* and *TLR5* remain scarce or are lacking. Further investigations on *TLR* polymorphisms, including haplotype analysis along with gene-environment interaction, are needed.

SNPs, which occur at every 1.9 kb in the genome on average,[@B73] could result in reduced or increased gene expression when they occur in promoter.[@B74] This meta-analysis did not control for multiple known risk factors for asthma, such as age, gender, and ethnicity. These potential confounding factors may interact with *TLR* polymorphisms to moderate asthma susceptibility. Genetic associations were shown to be significantly influenced by age[@B75],[@B76],[@B77],[@B78] likely because some genes are expressed in adults and not expressed in children and *vice versa*. Observational studies showed that the prevalence of asthma has increased during the last decade due to environmental factors.[@B3] Therefore, it is important to investigate other polymorphisms in *TLRs*, as well as gene-gene and gene-environment interactions. A possible gene-environment interaction has been reported,[@B79] in which the SNPs act as modifiers of asthma risk in individuals with various degrees of environmental endotoxin exposure. Future studies should include haplotype analysis and stratification of the study population according to related environmental risk factors.

Asthma is a complex disease involving several genes that might be more relevant than *TLR* genes. Although statistically significant, the effect of the *TLRs* on asthma was modest. This result may reflect the important role of other confirmed candidate genes in asthma disease. It has been reported that many genes are involved and make small contributions to the overall asthma phenotype.

The findings of our meta-analyses are consistent with experimental studies demonstrating that *TLR* polymorphisms are important factors in asthma disease, and support the need for further research into the mechanisms underlying asthma susceptibility. The significant association between *TLR* polymorphisms and asthma risk may be of clinical and public health importance. Further meta-analyses and studies on the expression of related genes, environmental factors, and gene-gene and gene-environment interactions would provide useful information for the prevention and treatment of asthma.

The recent discovery of TLRs, with their role as initiators of the innate immune response and inflammation, suggests that modulating these receptors may be beneficial in the treatment of allergic disorders.[@B7] TLRs are currently being exploited as possible targets for drug development.[@B80] Recently, several patents aimed to modulate the innate immune reaction occurring in asthma through the use of novel synthetic TLR2 ligands[@B8],[@B11]; these open new therapeutic perspectives for the prevention of these pathologies. Greater knowledge of risk factors will translate into improved diagnosis, prevention and therapeutic strategies for this chronic disease.
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![Forest plot of the association between *TLR4 Asp299Gly* and asthma risk: AA vs AG+GG. The forest plot shows the odds ratios (ORs) and respective 95% confidence intervals (CIs) for the studies included in the meta-analysis. For each study in the forest plot, the area of the black square is proportional to the study weight, and the horizontal bar represents the 95% CI. Z score: the standardized expression of a value in terms of its relative position in the full distribution of values.](aair-7-130-g002){#F2}

![Forest plot of the association between *TLR4 Thr399Ile* and asthma risk: C allele vs T allele. The forest plot shows the ORs and respective 95% CIs for the studies included in the meta-analysis. For each study in the forest plot, the area of the black square is proportional to the study weight, and the horizontal bar represents the 95% CI. Z score: the standardized expression of a value in terms of its relative position in the full distribution of values.](aair-7-130-g003){#F3}

![Forest plot of the association between *TLR2 Arg753Gln* and asthma: GG+AA vs GA. The forest plot shows the ORs and respective 95% CIs for the studies included in the meta-analysis. For each study in the forest plot, the area of the black square is proportional to the study weight, and the horizontal bar represents the 95% CI. Z score: the standardized expression of a value in terms of its relative position in the full distribution of values.](aair-7-130-g004){#F4}

![Forest plot of the association between *TLR9 -1237* and asthma: T allele vs C allele. The forest plot shows the (ORs and respective 95% CIs for the studies included in the meta-analysis. For each study in the forest plot, the area of the black square is proportional to the study weight, and the horizontal bar represents the 95% CI. Z score: the standardized expression of a value in terms of its relative position in the full distribution of values.](aair-7-130-g005){#F5}

###### Characteristics of the reviewed studies on SNPs in *TLR* genes and asthma risk

![](aair-7-130-i001)

  Reference                 Ethnicity               Age: Case/control         Gender           Gene       Polymorphism      Case   Control   Results
  ------------------------- ----------------------- ------------------------- ---------------- ---------- ----------------- ------ --------- ---------
  Lazarus 2003              European-American       Matched                   Matched          *TLR9*     rs5743836 T/C     64     114       SA
  Noguchi 2004              Japanese (Chinese)      Children/46.9             Matched          *TLR2*     c\. -191 G\>A     133    186       NS
  c\. 597 T\>C              133                     188                       NS                                                             
  c\. 1350 T\>C             134                     190                       NS                                                             
  *TLR3*                    -7A                     135                       189              NS                                            
  IVS3 +71 C\>A             134                     188                       NS                                                             
  c\. 1377 C\>T             133                     189                       NS                                                             
  *TLR9*                    c\. 1635 G\>A           132                       189              NS                                            
  Tantisira 2004            African-American        Matched                   Matched          *TLR6*     Ser249Pro C\>T    56     97        SA
  Lazarus 2004              European-American       Matched                   Matched          *TLR10*    c.+1031 G\>T      506    514       SA
  c.+2322 A\>G              505                     513                       SA                                                             
  Yang 2004                 English (Caucasian)     Matched                   Matched          *TLR4*     rs4986790 A\>G    320    184       NS
  Matched                   Matched                 *TLR4*                    rs4986790 A\>G   309        184               NS               
  Matched                   Matched                 *TLR4*                    rs4986790 A\>G   185        184               NS               
  Hoffjan 2005              German (Caucasian)      38/59                     Matched          *TLR6*     Ser249Pro C\>T    68     212       NS
  9.5/59                    Ser249Pro C\>T          132                       212              NS                                            
  Smit 2007                 Danish (Caucasian)      19.2/matched              Matched          *TLR2*     rs4696480 A\>T    100    87        NS
  rs5743704 C\>A            100                     87                        NS                                                             
  rs5743708 C\>T            100                     87                        NS                                                             
  *TLR4*                    rs4986790 A\>G          100                       87               NS                                            
  rs4986791 C\>T            100                     87                        NS                                                             
  Caravalho 2008            European (Caucasians)   57.6±11.8/not mentioned   Matched          *TLR2*     rs5743708 G\>A    14     80        NS
  *TLR4*                    rs4986790 A\>G          14                        80               NS                                            
  *TLR9*                    rs5743836 T\>C          14                        80               NS                                            
  Lachheb 2008              African Caucasian       10.5/8                    Matched          *TLR2*     rs5743708 C\>T    210    224       NS
  *TLR4*                    rs4986790 A\>G          210                       224              NS                                            
  rs4986791 C\>T            210                     224                       NS                                                             
  *TLR9*                    rs5743836 T\>C          210                       224              SA                                            
  rs187084 T\>C             210                     224                       NS                                                             
  Larocca 2008              Venezuelan (American)   44.6±15.22/42.63±13.89    Matched          *T LR4*    rs4986790 A\>G    100    100       NS
  rs4986791 C\>T            100                     100                       NS                                                             
  Bjørnvold 2009            Norwegian (Caucasian)   Children                  Matched          *TLR2*     Rs3804100 T\>C    108    494       SA
  *TLR2*                    Rs3804099T\>C           108                       494              NS                                            
  Hseih 2009                Taiwanese (Asian)       7.2±2.4/Children          Matched          *TLR4*     rs10983755 A\>G   117    60        NS
  rs1927914 C\>T            117                     60                        NS                                                             
  Zhang 2009                Chinese (Asian)         39.80±14.23/34.27±13.31   Male             *TLR7/8*   rs5935436 C\>T    135    200       SA
  rs3761623 A\>G            135                     200                       NS                                                             
  rs3764880 G\>A            135                     200                       NS                                                             
  39.80±14.23/34.27±13.31   Female                  *TLR7/8*                  rs5935436 C\>T   183        152               NS               
  rs3761623 A\>G            183                     151                       SA                                                             
  rs3764880 G\>A            182                     152                       SA                                                             
  Qian 2010                 Chinese (Asian)         39.80/38.26               Matched          *TLR1*     rs4833095 C\>T    318    351       NS
  *TLR2*                    rs7656411 G\>T          317                       351              SA                                            
  *TLR6*                    rs5743831 A\>G          318                       352              NS                                            
  rs5743808 T\>C            318                     351                       NS                                                             
  rs2381289 C\>T            318                     352                       NS                                                             
  *TLR10*                   rs11466651 G\>A         318                       352              NS                                            
  rs11466655 A\>G           318                     351                       NS                                                             
  rs4504265 C\>A            317                     349                       NS                                                             
  Zhang 2011                Chinese (Asian)         39.80/38.26               Matched          *TLR4*     rs1927914 T\>C    318    350       SA^\*^
  rs10983755 G\>A           318                     351                                                                                      
  rs11536879 A\>G           304                     348                                                                                      
  rs1927907 G\>A            314                     334                                                                                      
  Palikhe 2011              Korean (Asian)          43.1±15.2/32.1±12.7       Matched          *TLR3*     rs3775296 G\>T    254    274       NS
  rs3775291 G\>A            254                     274                       NS                                                             
  Vorvonko 2011             Russian (Caucasian)     Adults/38.5±10.4          Matched          *TLR4*     rs4986790 A\>G    283    227       NS
  Qian 2011                 Chinese (Asian)         1.9-11.6/matched          Matched          *TLR9*     rs187084 C/T      312    339       NS
  Hussein 2012              African Caucasian       8.4±2.6/10.1±2.3          Matched          *TLR2*     rs5743708 G\>A    500    250       SA^\*^
  *TLR4*                    rs4986790 A\>G          500                       251                                                            
  Şahin 2014                Turkish (Caucasian)     36±12.42/43±7.68          Matched          *TLR4*     rs4986790 A\>G    131    75        NS
  rs4986791 C\>T            131                     75                        SA                                                             

NS, non significant association; SA, significant association; SA^\*^, significant association with asthma severity.

###### Association of *TLR4 Asp299Gly A/G*, *TLR4 Thr399Ile* *C*\>*T*, *TLR2 Arg753Gln G/A* and *TLR9 -1237 T/C* with asthma risk

![](aair-7-130-i002)

  TLRs                            Genetic model                                 OR                    *P*-value   *I*^2^   Egger *P*
  ------------------------------- ---------------------- ---------------------- --------------------- ----------- -------- -----------
  *TLR4 Asp299Gly A*\>*G* (n=8)   Recessive              AA vs AG+GG            0.814 (0.652-1.016)   **0.069**   0.000    0.25
  Homozygous                      GG+AA vs AG            0.835 (0.666-1.047)    0.118                 0.000       0.40     
  Dominant                        AA+AG vs GG            0.857 (0.297-2.477)    0.776                 0.000       0.42     
  Codominant^\*^                  AA vs GG               0.897 (0.597-1.346)    0.599                 0.000       0.12     
  Codominant^\*^                  AG vs GG               0.831 (0,663-1.042)    0.110                 0.000       0.40     
  Codominant^\*^                  AA vs AG               0.972 (0.320-2.953)    0.960                 0.000       0.28     
  Allele contrast                 A allele vs G allele   0.814 (0.659-1.005)    **0.055**             0.000       0.05     
  *TLR4 Thr399Ile C*\>*T* (n=4)   Recessive              CC vs TC+TT            0.784 (0.571-1.075)   0.130       0.00     0.15
  Homozygous                      CC+TT vs TC            1.315 (0.688-2.513)    0.408                 0.00        0.45     
  Dominant                        CC+TC vs TT            0.708 (0.111-4522)     0.715                 0.00        0.05     
  Codominant                      CC vs TT               1.223 (0.655-2.286)    0.527                 0.00        0.34     
  Codominant                      CT vs TT               1.306 (0.683-2.497)    0.419                 0.00        0.45     
  Codominant                      CC vs TC               0.398 (0.053-3.006)    0.372                 0.00        0.03     
  Allele contrast                 C allele vs T allele   1.132 (0.623-2.056)    0.684                 0.00        0.34     
  *TLR2 Arg753Gln G*\>*A* (n=4)   Recessive              GG vs GA+AA            0.968 (0.441-2.123)   0.935       18.71    0.37
  Homozygous                      GG+AA vs GA            2.476 (0.483-12.698)   0.277                 57.34       0.30     
  Dominant                        GG+GA vs AA            0.100 (0.013-0.789)    **0.029**             0.00        \-       
  Codominant                      GG vs AA               0.102 (0.013-0.803)    **0.030**             0.00        \-       
  Codominant                      GA vs AA               0.01 (0.001-0.312)     **0.009**             24.25       \-       
  Codominant                      GG vs GA               2.451 (0.483-12.441)   0.279                 56.82       0.30     
  Allele contrast                 G allele vs A allele   0.635 (0.228-1.771)    0.385                 52.24       0.47     
  *TLR9-1237 T*\>*C* (n=3)        Recessive              TT vs TC+CC            0.950 (0.570-1.583)   0.223       33.33    0.41
  Homozygous                      TT+CC vs TC            1.267 (0.867-1.852)    0.222                 0.00        0.39     
  Dominant                        TT+TC vs CC            0.684 (0.090-5.192)    0.714                 85.96       \-       
  Codominant^\*^                  TT vs CC               0.408 (0.163-1.021)    **0.065**             30.95       \-       
  Codominant^\*^                  TC vs CC               0.498 (0.206-1.202)    0.121                 16.83       \-       
  Codominant^\*^                  TT vs TC               0.876 (0.584-1.315)    0.525                 0.00        0.12     
  Allele contrast                 T allele vs C allele   0.689 (0.471-1.007)    **0.055**             18.73       0.27     

*TLR4 Asp299Gly* (rs 4986790); *TLR4 Thr399Ile* (rs4986791); *TLR2 Arg753Gln* (rs5743708); *TLR9 -1237* (rs187084); Bold: significant *P* value (\<0.05). *TLR4 Asp299Gly* polymorphism: one study removed,[@B60] OR=0.803 (0.647-0.997); *P*=0.047 in the allele contrast model. *TLR2 Arg753Gln* polymorphism: one study removed,[@B61] OR=4.460 (1.213-16.396); *P*=0.024 in the homozygous model; one study removed,[@B61] OR=4.365 (1.2265-15.536); *P*=0.023 in the GG vs GA codominant model; one study removed,[@B60] OR=0.402 (0.199-0.811); *P*=0.011 in the allele contrast model.

n, number of studies; OR, odds ratio; *I*^2^, heterogeneity test.

^\*^best-fitted genetic model.
